Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Pokrovskaya, M. Pokrovsky, E. Dudina, E. Konovalova, V. Kochkarov, I. Kolesnik, M. Korokin, O. Gudyrev, A. Arustamova, R. Bontsevich, A. Chetverikova, I. Korobtsova (Belgorod, Kursk, Russian Federation). Correction of endothelial dysfunction by inhibitors of phosphodiesterase-5 in combination with L-arginine. Eur Respir J 2013; 42: Suppl. 57, 496

Member's Comments

No comment yet.

Related content which might interest you: Endothelial, inducible and neuronal nitric oxide synthase in congenital pulmonary lymphangiectasis Source: Eur Respir J 2006; 27: 1311-1315 Year: 2006 Nitric oxide in primary ciliary dyskinesia}, Source: Eur Respir J 2012; 40: 1024-1032 Year: 2012 Inhaled nitric oxide decreases pulmonary endothelial nitric oxide synthase expression and activity in normal newborn rat lungs Source: ERJ Open Res 2016 Year: 2016 Inhaled nitric oxide (NO) for vasoreactivity testing in pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 584s Year: 2003 Differential action of beraprost isomers on prostacyclin (IP) receptors and PPARβ in pulmonary arteries Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Effects of endothelial nitric oxide synthase enzyme, angiotensin converting enzyme and serotonin transporter genotypes on pulmonary hypertension in COPD Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Infused nitric oxide in experimental pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 348s Year: 2007 Nitric oxide metabolism in COPD comorbidities Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014 Exhaled nitric oxide levels in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 The role of nitric oxide (NO) on sepsis-induced pulmonary apoptosis Source: Eur Respir J 2001; 18: Suppl. 33, 358s Year: 2001 Acute vasoreactivity testing with sildenafil vs nitric oxide in patients with PAH Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 Influence of inhaled nitric oxide on plasma endothelin-1 in pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 463s Year: 2003 Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Reduce expression of endothelial nitric oxide synthase lead to more severe pulmonary complex vascular lesions associated with HIV Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Limitations of nasal nitric oxide as a screening method of primary ciliary dyskinesia in childhood Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 Effect of the Asp298 variant of endothelial nitric oxide synthase on acute pulmonary vasodilator testing response in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 547s Year: 2006 Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia Source: Eur Respir J 2011; 37: 572-577 Year: 2011 Inhaled no decreased endothelial nitric oxide synthase expression in normal newborn rat lungs Source: Annual Congress 2009 - Respiratory disorders of the newborn Year: 2009 Expression of endothelial nitric oxide synthase (eNOS) and endothelin-1 (ET-1) in pulmonary arteries of patients with severe COPD Source: Annual Congress 2003 - Pathophysiology of the pulmonary circulation Year: 2003 Nasal nitric oxide Source: Eur Respir Monogr 2010; 49: 71-81 Year: 2010